SCHEMBL5769339

SCHEMBL5769339

CCN(CC)C(=O)C(C)N.COC(=O)[C@H](C)N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
CHRNB2 P17787 3/20 0.32
CHRNB4 P30926 3/20 0.32
CHRNA3 P32297 3/20 0.32
CHRNA4 P43681 3/20 0.32
CA14 Q9ULX7 1/20 0.31
ZDHHC7 Q9NXF8 1/20 0.31
HTT P42858 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5769336 1.00 DPP4 (0.35) DPP4ALDH1A1SMN1; SMN2CA1CA2
SCHEMBL5438409 0.85 DPP4 (0.42) DPP4ALDH1A1SMN1; SMN2CA1HTT
SCHEMBL3948078 0.85 DPP4 (0.42) DPP4ALDH1A1SMN1; SMN2CA1HTT
SCHEMBL104803 0.78
SCHEMBL41892 0.78
SCHEMBL30039818 0.78
SCHEMBL72838 0.78
Alcohol SCHEMBL27641962 0.77 SMN1; SMN2 (0.39) SMN1; SMN2CA1CA2GRIN2DGRIN3B
SCHEMBL25301326 0.76
SCHEMBL4106004 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633349-A1 4-BROMO-5- (2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (1-(AMINOCARBONYL) ETH-1-YL) AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-15 EP disclosed
WO-2004098590-A1 4-BROMO-5- (2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (1-(AMINOCARBONYL) ETH-1-YL) AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO disclosed